PLRX
Price
$1.50
Change
-$0.07 (-4.46%)
Updated
Nov 19, 04:59 PM (EDT)
Capitalization
95.86M
104 days until earnings call
Intraday BUY SELL Signals
VCEL
Price
$38.76
Change
-$0.27 (-0.69%)
Updated
Nov 19, 02:04 PM (EDT)
Capitalization
1.97B
99 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

PLRX vs VCEL

Header iconPLRX vs VCEL Comparison
Open Charts PLRX vs VCELBanner chart's image
Pliant Therapeutics
Price$1.50
Change-$0.07 (-4.46%)
Volume$58.98K
Capitalization95.86M
Vericel
Price$38.76
Change-$0.27 (-0.69%)
Volume$200
Capitalization1.97B
PLRX vs VCEL Comparison Chart in %
PLRX
Daily Signal:
Gain/Loss:
VCEL
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
PLRX vs. VCEL commentary
Nov 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PLRX is a Hold and VCEL is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 19, 2025
Stock price -- (PLRX: $1.56 vs. VCEL: $39.02)
Brand notoriety: PLRX and VCEL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PLRX: 170% vs. VCEL: 50%
Market capitalization -- PLRX: $95.86M vs. VCEL: $1.97B
PLRX [@Biotechnology] is valued at $95.86M. VCEL’s [@Biotechnology] market capitalization is $1.97B. The market cap for tickers in the [@Biotechnology] industry ranges from $110.5B to $0. The average market capitalization across the [@Biotechnology] industry is $2.15B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PLRX’s FA Score shows that 0 FA rating(s) are green whileVCEL’s FA Score has 0 green FA rating(s).

  • PLRX’s FA Score: 0 green, 5 red.
  • VCEL’s FA Score: 0 green, 5 red.
According to our system of comparison, both PLRX and VCEL are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PLRX’s TA Score shows that 3 TA indicator(s) are bullish while VCEL’s TA Score has 6 bullish TA indicator(s).

  • PLRX’s TA Score: 3 bullish, 7 bearish.
  • VCEL’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, VCEL is a better buy in the short-term than PLRX.

Price Growth

PLRX (@Biotechnology) experienced а -6.59% price change this week, while VCEL (@Biotechnology) price change was -4.95% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.17%. For the same industry, the average monthly price growth was -5.68%, and the average quarterly price growth was +64.91%.

Reported Earning Dates

PLRX is expected to report earnings on Mar 03, 2026.

VCEL is expected to report earnings on Feb 26, 2026.

Industries' Descriptions

@Biotechnology (-2.17% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VCEL($1.97B) has a higher market cap than PLRX($95.9M). VCEL YTD gains are higher at: -28.938 vs. PLRX (-88.155). VCEL has higher annual earnings (EBITDA): 16.2M vs. PLRX (-201.76M). PLRX has more cash in the bank: 263M vs. VCEL (117M). PLRX has less debt than VCEL: PLRX (60.4M) vs VCEL (99.8M). VCEL has higher revenues than PLRX: VCEL (249M) vs PLRX (0).
PLRXVCELPLRX / VCEL
Capitalization95.9M1.97B5%
EBITDA-201.76M16.2M-1,245%
Gain YTD-88.155-28.938305%
P/E RatioN/A151.65-
Revenue0249M-
Total Cash263M117M225%
Total Debt60.4M99.8M61%
FUNDAMENTALS RATINGS
VCEL: Fundamental Ratings
VCEL
OUTLOOK RATING
1..100
21
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
PROFIT vs RISK RATING
1..100
72
SMR RATING
1..100
85
PRICE GROWTH RATING
1..100
52
P/E GROWTH RATING
1..100
99
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
PLRXVCEL
RSI
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
80%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
85%
Momentum
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
78%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
72%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
76%
Advances
ODDS (%)
Bullish Trend 8 days ago
77%
Bullish Trend 9 days ago
78%
Declines
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
72%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
80%
Aroon
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
72%
View a ticker or compare two or three
Interact to see
Advertisement
PLRX
Daily Signal:
Gain/Loss:
VCEL
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GMALF0.59N/A
N/A
Genting Malaysia Berhad
MCRXF0.07N/A
N/A
MICRO X LTD.
PLSH0.07N/A
N/A
Panacea Life Sciences Holdings, Inc.
KNBHF95.03-0.61
-0.64%
Knorr Bremse Ag
UURAF4.45-0.51
-10.28%
Ucore Rare Metals, Inc.

VCEL and

Correlation & Price change

A.I.dvisor indicates that over the last year, VCEL has been loosely correlated with VCYT. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if VCEL jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VCEL
1D Price
Change %
VCEL100%
-1.04%
VCYT - VCEL
52%
Loosely correlated
-1.35%
AXON - VCEL
38%
Loosely correlated
-1.74%
AMRN - VCEL
36%
Loosely correlated
+4.33%
RAPT - VCEL
34%
Loosely correlated
-1.31%
PLRX - VCEL
33%
Poorly correlated
-5.45%
More